Gentile I - Search Results

1

Cytometric analysis of patients with COVID-19: what is changed in the second wave?

Scalia G, Raia M, Gelzo M, Cacciapuoti S, De Rosa A, Pinchera B, Scotto R, Giaccone A, Mormile M, Fabbrocini G, Gentile I, Parrella R, Castaldo G. Scalia G, et al. Among authors: gentile i. J Transl Med. 2021 Sep 23;19(1):403. doi: 10.1186/s12967-021-03072-1. J Transl Med. 2021. PMID: 34556132 Free PMC article.

2

Telaprevir: a promising protease inhibitor for the treatment of hepatitis C virus infection.

Gentile I, Viola C, Borgia F, Castaldo G, Borgia G. Gentile I, et al. Curr Med Chem. 2009;16(9):1115-21. doi: 10.2174/092986709787581789. Curr Med Chem. 2009. PMID: 19275615 Review.

3

The efficacy and safety of telaprevir - a new protease inhibitor against hepatitis C virus.

Gentile I, Carleo MA, Borgia F, Castaldo G, Borgia G. Gentile I, et al. Expert Opin Investig Drugs. 2010 Jan;19(1):151-9. doi: 10.1517/13543780903501505. Expert Opin Investig Drugs. 2010. PMID: 20001560 Review.

4

A novel promising therapeutic option against hepatitis C virus: an oral nucleotide NS5B polymerase inhibitor sofosbuvir.

Gentile I, Borgia F, Buonomo AR, Castaldo G, Borgia G. Gentile I, et al. Curr Med Chem. 2013;20(30):3733-42. doi: 10.2174/09298673113209990178. Curr Med Chem. 2013. PMID: 23848533 Review.

5

Efficacy and Safety of Sofosbuvir in the Treatment of Chronic Hepatitis C: The Dawn of a New Era.

Gentile I, Borgia F, Zappulo E, Buonomo AR, Spera AM, Castaldo G, Borgia G. Gentile I, et al. Rev Recent Clin Trials. 2014;9(1):1-7. doi: 10.2174/1574887108666131213120354. Rev Recent Clin Trials. 2014. PMID: 23859195 Review.

6

Daclatasvir: the first of a new class of drugs targeted against hepatitis C virus NS5A.

Gentile I, Borgia F, Coppola N, Buonomo AR, Castaldo G, Borgia G. Gentile I, et al. Curr Med Chem. 2014;21(12):1391-404. doi: 10.2174/0929867321666131228222215. Curr Med Chem. 2014. PMID: 24372205 Review.

7

Ledipasvir : a novel synthetic antiviral for the treatment of HCV infection.

Gentile I, Buonomo AR, Borgia F, Castaldo G, Borgia G. Gentile I, et al. Expert Opin Investig Drugs. 2014 Apr;23(4):561-71. doi: 10.1517/13543784.2014.892581. Epub 2014 Mar 4. Expert Opin Investig Drugs. 2014. PMID: 24593285 Review.

8

MK-5172 : a second-generation protease inhibitor for the treatment of hepatitis C virus infection.

Gentile I, Buonomo AR, Borgia F, Zappulo E, Castaldo G, Borgia G. Gentile I, et al. Expert Opin Investig Drugs. 2014 May;23(5):719-28. doi: 10.1517/13543784.2014.902049. Epub 2014 Mar 26. Expert Opin Investig Drugs. 2014. PMID: 24666106 Review.

9

ABT-450: a novel protease inhibitor for the treatment of hepatitis C virus infection.

Gentile I, Borgia F, Buonomo AR, Zappulo E, Castaldo G, Borgia G. Gentile I, et al. Curr Med Chem. 2014;21(28):3261-70. doi: 10.2174/0929867321666140706125950. Curr Med Chem. 2014. PMID: 25005190 Review.

10

Low vitamin D levels are associated with the presence of serum cryoglobulins in patients with chronic HCV infection.

Gentile I, Scarano F, Celotti A, DE Iuliis E, Scarano R, Granata V, Pinchera B, Meola M, D'Ambra A, Piccirillo M, DI Paola F, Cavalcanti E, Izzo F, Scarpato N, Borgia G. Gentile I, et al. In Vivo. 2015 May-Jun;29(3):399-404. In Vivo. 2015. PMID: 25977388

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

359 results

Search Page

Filters